You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 337Biotin 44HRP 32FITC 30PE 29APC 26Cy3 14AP 12iFluor647 9IRDye800 8APC/Cy7 6PE/Cy5.5 6PE/Cy7 6APC/Cy5.5 5BF350 5BF405 5BF488 5BF555 5BF594 5BF647 5BF680 5BF700 5BF750 5Cy5 5Cy5.5 5Cy7 5PE/Cy5 5Pacific Blue 5PerCP 5PerCP/Cy5.5 5PerCP/Cy7 5RBITC 5AE 1IRDye800CW 1PE/Texas Red 1RPE 1SureLight 488 1
Biologically Active
Featured Product
Human IL-4 RA [orb2994196]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 50.2 KDa. Observed: 60-70 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Human IL-4 RA [orb2994200]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.4 KDa. Observed: 35-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human IL-4 RA [orb2994735]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 50.2 KDa. Observed: 65-86 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human STAT6 [orb2994611]
Unconjugated
SDS-PAGE: Greater than 85% as determined by reducing SDS-PAGE.
Predicted: 23.9 KDa. Observed: 30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human IL-4RA [orb2992716]
SDS-PAGE: Greater than 95% as determined by SDS-PAGE. (QC verified)
Predicted: 26.2 KDa. Observed: 35-65 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human IL-4 [orb2992735]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 17.8 KDa. Observed: 17-25 KDa, reducing conditions
100 μg, 20 μg 
- Item 1 of 3IL-4R Rabbit Polyclonal Antibody [orb499584]Featured
ICC, WB
Human
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl, 200 μl
